Diagnostic Test
Partial Thromboplastin Time
Diagnostics
Overview
The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Partial Thromboplastin Time
- Topic type
- Diagnostic Test
- Category
- Diagnostics
- MeSH classification
- E01.370.225.625.115.600|E05.200.625.115.600|G09.188.660
Questions to discuss about Partial Thromboplastin Time
- What does this topic mean in my situation?
- Which type of healthcare professional should I speak with?
- Are tests, assessments or follow-up appointments needed?
- What treatment options or next steps may be relevant?
- Where can I find reliable information before making decisions?
Finding care related to Partial Thromboplastin Time
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Partial Thromboplastin Time
No clinics are currently linked directly to Partial Thromboplastin Time on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.